Metastatic Colorectal Cancer Carcinoma clinical trials

Explore recruiting metastatic colorectal cancer carcinoma clinical trials.

Recruiting metastatic colorectal cancer carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Metastatic Colorectal Cancer Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

REPROGRAM-02 : Induction Regorafenib in combination with metronomic cyclophosphamide, capecitabine, and low-dose aspirin followed by chemotherapy in second line metastatic colorectal cancer carcinoma An open-label randomized phase II-III study

France

Phase II and Phase III (Integrated) EU CTIS Study details

Metastatic Colorectal Cancer Carcinoma trials by city

Metastatic Colorectal Cancer Carcinoma clinical trials

Recruiting metastatic colorectal cancer carcinoma studies right now

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

A Study of YL202 in Patients With Advanced Solid Tumors

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC

Also recruiting in Europe

REPROGRAM-02 : Induction Regorafenib in combination with metronomic cyclophosphamide, capecitabine, and low-dose aspirin followed by chemotherapy in second line metastatic colorectal cancer carcinoma An open-label randomized phase II-III study

Metastatic Colorectal Cancer Carcinoma trials by city

Other conditions